{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:34:22Z","timestamp":1788298462916,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009141","name":"Cancer League of Colorado","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jcf.2019.08.003","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T04:53:35Z","timestamp":1572756815000},"page":"S10-S18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"S2","title":["Cystic fibrosis related diabetes: Medical management"],"prefix":"10.1016","volume":"18","author":[{"given":"Katie Larson","family":"Ode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3067-7672","authenticated-orcid":false,"given":"Christine L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-6267","authenticated-orcid":false,"given":"Andrea","family":"Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9909-6724","authenticated-orcid":false,"given":"Amir","family":"Moheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcf.2019.08.003_bb0005","first-page":"344","article-title":"Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study","volume":"56","author":"Andersen","year":"1938","journal-title":"JAMA Pediatr"},{"issue":"12","key":"10.1016\/j.jcf.2019.08.003_bb0010","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.003_bb0015","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2337\/dc10-2289","article-title":"Hyperglycemia and death in cystic fibrosis-related diabetes","volume":"34","author":"Adler","year":"2011","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.003_bb0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.jcf.2019.08.003_bb0025","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.003_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3476(98)70171-4","article-title":"Abnormal glucose metabolism in cystic fibrosis","volume":"133","author":"Moran","year":"1998","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.jcf.2019.08.003_bb0035","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.2337\/dc10-0613","article-title":"Impaired fasting glucose in cystic fibrosis","volume":"33","author":"Frohnert","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.003_bb0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/eje.0.1490053","article-title":"Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia","volume":"149","author":"Lombardo","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.003_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1464-5491.2002.00666.x","article-title":"Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction","volume":"19","author":"Yung","year":"2002","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.003_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-10-1003","article-title":"Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients","volume":"165","author":"Battezzati","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.003_bb0055","first-page":"246","article-title":"Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype","volume":"35","author":"Street","year":"2012","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.003_bb0060","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2337\/diabetes.48.5.1082","article-title":"Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis","volume":"48","author":"Hardin","year":"1999","journal-title":"Diabetes."},{"issue":"S2","key":"10.1016\/j.jcf.2019.08.003_bb0065","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jcf.2019.08.011","article-title":"Cystic fibrosis related diabetes: Nutrition and growth considerations","volume":"18","author":"Kaminski","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.003_bb0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1249\/MSS.0000000000001104","article-title":"Combined exercise training improves glycemic control in adult with cystic fibrosis","volume":"49","author":"Beaudoin","year":"2017","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.003_bb0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clnu.2011.09.007","article-title":"Insulin secretion, nutritional status and respiratory function in cystic fibrosis patients with normal glucose tolerance","volume":"31","author":"Alicandro","year":"2012","journal-title":"Clin Nutr (Edinb Scotl)"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.003_bb0080","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1152\/japplphysiol.01425.2006","article-title":"Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis","volume":"102","author":"Baker","year":"2007","journal-title":"J Appl Physiol (1985)"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.003_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcf.2006.03.009","article-title":"Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis","volume":"6","author":"Brennan","year":"2007","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.003_bb0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ajcn.81.2.421","article-title":"Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis","volume":"81","author":"Rafii","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.003_bb0095","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/193229681200600507","article-title":"Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions","volume":"6","author":"Rasouli","year":"2012","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.003_bb0100","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.clnu.2014.08.016","article-title":"Carbohydrate intake and insulin requirement in children, adolescents and young adults with cystic fibrosis-related diabetes: a multicenter comparison to type 1 diabetes","volume":"34","author":"Scheuing","year":"2015","journal-title":"Clin Nutr (Edin Scotl)"},{"issue":"3 Pt 1","key":"10.1016\/j.jcf.2019.08.003_bb0105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/ajrccm.162.3.9904075","article-title":"Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline","volume":"162","author":"Milla","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.003_bb0110","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"Suppl. 27","key":"10.1016\/j.jcf.2019.08.003_bb0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/pedi.12732","article-title":"ISPAD clinical practice consensus guidelines 2018: management of cystic fibrosis-related diabetes in children and adolescents","volume":"19","author":"Moran","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.003_bb0120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jcf.2019.01.009","article-title":"The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity","volume":"18","author":"Colomba","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.003_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/pedi.12014","article-title":"Exogenous insulin requirements do not differ between youth and adults with cystic fibrosis related diabetes","volume":"14","author":"Sunni","year":"2013","journal-title":"Pediatr Diabetes"},{"issue":"9","key":"10.1016\/j.jcf.2019.08.003_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044844","article-title":"Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis","volume":"7","author":"Widger","year":"2012","journal-title":"PLoS One"},{"issue":"S2","key":"10.1016\/j.jcf.2019.08.003_bb0135","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jcf.2019.08.025","article-title":"Continuous glucose monitoring in cystic fibrosis - A practical guide","volume":"18","author":"Chan","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.003_bb0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcf.2008.12.001","article-title":"Use of the insulin pump in treat cystic fibrosis related diabetes","volume":"8","author":"Hardin","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.003_bb0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jcf.2007.07.004","article-title":"Glargine versus NPH insulin in cystic fibrosis related diabetes","volume":"7","author":"Grover","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.003_bb0150","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jpeds.2012.08.040","article-title":"Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis","volume":"162","author":"Yen","year":"2013","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.003_bb0155","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto","volume":"41","author":"Corey","year":"1988","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.jcf.2019.08.003_bb0160","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.jand.2017.07.006","article-title":"Body weight and body mass index in patients with end-stage cystic fibrosis stabilize after the start of enteral tube feeding","volume":"117","author":"Hollander","year":"2017","journal-title":"J Acad Nutr Diet"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.003_bb0165","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4239\/wjd.v6.i8.1073","article-title":"Steroid hypergllycemia: prevalence, early detection and therapeutic recommendations: a narrative review","volume":"6","author":"Tamez-Perez","year":"2015","journal-title":"World J Diabetes"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.003_bb0170","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2337\/dc06-1576","article-title":"Microvascular complications in cystic fibrosis-related diabetes","volume":"30","author":"Schwarzenberg","year":"2007","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.003_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004730.pub2","article-title":"Insulin and oral agents for managing cystic fibrosis-related diabetes","author":"Onady","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.003_bb0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S2213-8587(17)30400-X","article-title":"Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial","volume":"6","author":"Ballmann","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.003_bb0185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcf.2011.11.001","article-title":"Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus","volume":"11","author":"Hillman","year":"2012","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.003_bb0190","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1210\/jc.2013-4417","article-title":"Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial","volume":"99","author":"Perano","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.003_bb0195","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/dom.13544","article-title":"Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: a randomized crossover trial","volume":"21","author":"Geyer","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"Supplement 1","key":"10.1016\/j.jcf.2019.08.003_bb0200","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/S1569-1993(19)30594-6","article-title":"Metformin tolerability in patients with CF","volume":"18","author":"Brennan","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.003_bb0205","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jcf.2017.01.018","article-title":"Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia","volume":"16","author":"Lehoux Dubois","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2019.08.003_bb0210","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.diabres.2016.04.014","article-title":"Cystic fibrosis-related diabetes with strict glycaemic control is not associated with frequent intravenous antibiotics use for pulmonary infections","volume":"116","author":"Belle-van Meerkerk","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"10.1016\/j.jcf.2019.08.003_bb0215","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.2337\/dc06-0654","article-title":"Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications","volume":"29","author":"Andersen","year":"2006","journal-title":"Diabetes Care"},{"issue":"1_suppl","key":"10.1016\/j.jcf.2019.08.003_bb0220","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1258\/jrsm.2010.s11010","article-title":"Ischaemic heart disease - a new issue in cystic fibrosis?","volume":"103","author":"Perrin","year":"2010","journal-title":"J R Soc Med"},{"issue":"S2","key":"10.1016\/j.jcf.2019.08.003_bb0225","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jcf.2019.08.004","article-title":"Hypoglycemia in cystic fibrosis: prevalence, impact and treatment","volume":"18","author":"Moheet","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.003_bb0230","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/JOE-18-0468","article-title":"Survival in a bad neighborhood: pancreatic islets in cystic fibrosis","volume":"241","author":"Norris","year":"2019","journal-title":"J Endocrinol"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.003_bb0235","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1164\/rccm.201806-1018OC","article-title":"Islet hormone and Incretin secretion in cystic fibrosis after four months of Ivacaftor therapy","volume":"199","author":"Kelly","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.003_bb0240","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pedi.12026","article-title":"Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study","volume":"14","author":"Bellin","year":"2013","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.003_bb0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ppul.24212","article-title":"Ventilation inhomogeneity is associated with OGTT-derived insulin secretory defects in cystic fibrosis","volume":"54","author":"Colombo","year":"2019","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.003_bb0250","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00592-015-0791-3","article-title":"The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis","volume":"53","author":"Coriati","year":"2016","journal-title":"Acta Diabetol"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.003_bb0255","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-5448.2008.00451.x","article-title":"One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements","volume":"10","author":"Mozzillo","year":"2009","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.003_bb0260","doi-asserted-by":"crossref","first-page":"RC1","DOI":"10.1007\/BF03345538","article-title":"Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance","volume":"29","author":"Bizzarri","year":"2006","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.003_bb0265","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/adc.2010.204636","article-title":"Once daily insulin detemir in cystic fibrosis with insulin deficiency","volume":"97","author":"Hameed","year":"2012","journal-title":"Arch Dis Child"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199319308355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199319308355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:41:10Z","timestamp":1761601270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199319308355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":53,"alternative-id":["S1569199319308355"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2019.08.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic fibrosis related diabetes: Medical management","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2019.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}